FDA.reportPublic FDA data

Philadelphia chromosome/BCR-ABL transcript IVD, control

Definition
A material which is used to verify the performance of an assay intended to be used to evaluate a clinical specimen to diagnose, monitor or predict chronic myeloid leukaemia (CML) or a subset of acute lymphoblastic leukaemia (ALL) associated with the Philadelphia chromosome, resulting from translocation t(9;22)(q34;q11) and rearrangement of the BCR and ABL genes.
GUDID devices
6
Last updated
2025-06-30 20:23:30

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
00852720008336Birlinn BCR-ABL1 p210 IS Panel C230Mmqciv.002025-06-20
00852720008367Birlinn BCR-ABL1 p210 IS Control Panel C240Mmqciv.002025-06-20
00852720008442Xpert BCR-ABL IS p210 Panel C206Mmqciv.002025-06-18
00852720008183Xpert BCR-ABL IS p210 Linearity Panel C207Mmqciv.002023-09-15
00852720008084Xpert BCR-ABL 0%ISMmqciv.002020-01-27
00852720008060Xpert BCR-ABL IS Panel C130Mmqciv.002019-12-04